Showing results (21-30 of 34) with videos related to
Sort By:
Pageof 4
Teratology|December 1, 1980
Embryotoxicity in mice of phosphonacetyl-L-aspartic acid (PALA), a new antitumor agent. I. Embryolethal, teratogenic, and cytogenetic effectsS M Sieber, C C Botkin, P Soong, et al.Bibliotheca Haematologica|January 1, 1975
Nonhuman primate models for lymphoma, leukemia, and other neoplasmsR H Adamson, K R McIntire, S M Sieber, et al.Journal of the National Cancer Institute|July 1, 1976
Carcinogenicity of aflatoxin B1 in rhesus monkeys: two additional cases of primary liver cancerR H Adamson, P Correa, S M Sieber, et al.Pharmacology|January 1, 1976
Serum sialic acid levels in lung cancer patientsF J Krolikowski, K Reuter, T P Waalkes, et al.Science (New York, N.Y.)|December 24, 1982
Monoclonal anitbodies in the lymphatics: toward the diagnosis and therapy of tumor metastasesJ N Weinstein, R J Parker, A M Keenan, et al.Toxicological Sciences : an Official Journal of the Society of Toxicology|February 1, 2000
Long-term toxicity and carcinogenicity study of cyclamate in nonhuman primatesS Takayama, A G Renwick, S L Johansson, et al.Cancer Treatment Reports|January 1, 1984
Monoclonal antitumor antibodies in the lymphaticsJ N Weinstein, M A Steller, D G Covell, et al.Cancer Research|April 15, 1987
Targeting of murine radiolabeled monoclonal antibodies in the lymphaticsR J Parker, A M Keenan, S K Dower, et al.Cancer Research|April 1, 1986
Optimization of monoclonal antibody delivery via the lymphatics: the dose dependenceM A Steller, R J Parker, D G Covell, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1987
Biodistribution of monoclonal IgG1, F(ab')2, and Fab' in mice after intravenous injection. Comparison between anti-B cell (anti-Lyb8.2) and irrelevant (MOPC-21) antibodiesO D Holton, C D Black, R J Parker, et al.Pageof 4